Toronto Dominion Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Toronto Dominion Bank's BIIB Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Biogen (BIIB) stake by 12% in Q1 2026, selling an estimated $1.07M and leaving 43,371 shares worth $7.95M. The position accounts for 0.01% of the portfolio, ranked #699.
Toronto Dominion Bank first reported a position in BIIB in Q4 2013 and has held it in 50 quarters since. The position peaked at $66.1M in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Toronto Dominion Bank held 43,371 shares of Biogen worth $7.95M as of Q1 2026.
- Toronto Dominion Bank sold 5,802 Biogen shares in Q1 2026, an estimated $1.07M.
- Biogen made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #699 holding.
- Toronto Dominion Bank first reported a position in Biogen in Q4 2013 and has held it in 50 quarters since.
- Toronto Dominion Bank's Biogen position peaked at $66.1M in Q1 2015.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.